Total parenteral (TPN) and enteral nutrition bags manufactured by Diffuplast: Sterilisation issue

Diffuplast has identified a potential issue with their third-party sterilisation provider. The MHRA have deemed the risk very low & therefore patients should continue to use their products as normal as the benefits of continuing treatment outweigh the potential risk of infection

SPS commentary:

A patient-specific communication regarding this matter is available from the Department of Health and Social Care.

Source:

Medicines and Healthcare products Regulatory Agency

Resource links:

Patient specific communication